{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:19:31Z","timestamp":1780679971181,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T00:00:00Z","timestamp":1315526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00330-011-2266-4","type":"journal-article","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T00:17:20Z","timestamp":1315441040000},"page":"458-467","source":"Crossref","is-referenced-by-count":61,"title":["Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours"],"prefix":"10.1007","volume":"22","author":[{"given":"Nils F.","family":"Schreiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munenobu","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich-Frank","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"R\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,9]]},"reference":[{"key":"2266_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000111037","volume":"87","author":"T Steinmuller","year":"2008","unstructured":"Steinmuller T, Kianmanesh R, Falconi M et al (2008) Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 87:47\u201362","journal-title":"Neuroendocrinology"},{"key":"2266_CR2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jso.21196","volume":"100","author":"SK Maithel","year":"2009","unstructured":"Maithel SK, Fong Y (2009) Hepatic ablation for neuroendocrine tumor metastases. J Surg Oncol 100:635\u2013638","journal-title":"J Surg Oncol"},{"key":"2266_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/bjs.6468","volume":"96","author":"A Frilling","year":"2009","unstructured":"Frilling A, Li J, Malamutmann E, Schmid KW, Bockisch A, Broelsch CE (2009) Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg 96:175\u2013184","journal-title":"Br J Surg"},{"key":"2266_CR4","first-page":"322","volume":"84","author":"T Berge","year":"1976","unstructured":"Berge T, Linell F (1976) Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Microbiol Scand A 84:322\u2013330","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"2266_CR5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/erc.1.01017","volume":"12","author":"F Panzuto","year":"2005","unstructured":"Panzuto F, Nasoni S, Falconi M et al (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12:1083\u20131092","journal-title":"Endocr Relat Cancer"},{"key":"2266_CR6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/gut.43.3.422","volume":"43","author":"I Madeira","year":"1998","unstructured":"Madeira I, Terris B, Voss M et al (1998) Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 43:422\u2013427","journal-title":"Gut"},{"key":"2266_CR7","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/annonc\/mdi358","volume":"16","author":"P Tomassetti","year":"2005","unstructured":"Tomassetti P, Campana D, Piscitelli L et al (2005) Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol 16:1806\u20131810","journal-title":"Ann Oncol"},{"key":"2266_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","volume":"197","author":"JM Sarmiento","year":"2003","unstructured":"Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG (2003) Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197:29\u201337","journal-title":"J Am Coll Surg"},{"key":"2266_CR9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1055-3207(02)00076-5","volume":"12","author":"JM Sarmiento","year":"2003","unstructured":"Sarmiento JM, Que FG (2003) Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 12:231\u2013242","journal-title":"Surg Oncol Clin N Am"},{"key":"2266_CR10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1067\/msy.2003.114","volume":"133","author":"D Elias","year":"2003","unstructured":"Elias D, Lasser P, Ducreux M et al (2003) Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery 133:375\u2013382","journal-title":"Surgery"},{"key":"2266_CR11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1072-7515(00)00222-2","volume":"190","author":"RS Chamberlain","year":"2000","unstructured":"Chamberlain RS, Canes D, Brown KT et al (2000) Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190:432\u2013445","journal-title":"J Am Coll Surg"},{"key":"2266_CR12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1072-7515(98)00099-4","volume":"187","author":"H Chen","year":"1998","unstructured":"Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA (1998) Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187:88\u201392, discussion 92\u201383","journal-title":"J Am Coll Surg"},{"key":"2266_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2463\/mrms.6.43","volume":"6","author":"CJ Zech","year":"2007","unstructured":"Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6:43\u201352","journal-title":"Magn Reson Med Sci"},{"key":"2266_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.200.1.8657946","volume":"200","author":"TJ Vogl","year":"1996","unstructured":"Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59\u201367","journal-title":"Radiology"},{"key":"2266_CR15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1148\/radiol.2301020269","volume":"230","author":"A Huppertz","year":"2004","unstructured":"Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266\u2013275","journal-title":"Radiology"},{"key":"2266_CR16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","volume":"34","author":"I Buchmann","year":"2007","unstructured":"Buchmann I, Henze M, Engelbrecht S et al (2007) Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 34:1617\u20131626","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2266_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","volume":"5","author":"J Kowalski","year":"2003","unstructured":"Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U (2003) Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 5:42\u201348","journal-title":"Mol Imaging Biol"},{"key":"2266_CR18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"M Gabriel","year":"2007","unstructured":"Gabriel M, Decristoforo C, Kendler D et al (2007) 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 48:508\u2013518","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"2266_CR19","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1007\/s00259-008-0951-6","volume":"36","author":"G Antoch","year":"2009","unstructured":"Antoch G, Bockisch A (2009) Combined PET\/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging 36(Suppl 1):S113\u2013120","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2266_CR20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2967\/jnumed.109.068510","volume":"51","author":"OF Donati","year":"2010","unstructured":"Donati OF, Hany TF, Reiner CS et al (2010) Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET\/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med 51:692\u2013699","journal-title":"J Nucl Med"},{"key":"2266_CR21","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2967\/jnumed.107.040378","volume":"48","author":"KP Zhernosekov","year":"2007","unstructured":"Zhernosekov KP, Filosofov DV, Baum RP et al (2007) Processing of generator-produced 68Ga for medical application. J Nucl Med 48:1741\u20131748","journal-title":"J Nucl Med"},{"key":"2266_CR22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2214\/AJR.08.1498","volume":"192","author":"RC Domingues","year":"2009","unstructured":"Domingues RC, Carneiro MP, Lopes FC, Domingues RC, da Fonseca LM, Gasparetto EL (2009) Whole-body MRI and FDG PET fused images for evaluation of patients with cancer. AJR Am J Roentgenol 192:1012\u20131020","journal-title":"AJR Am J Roentgenol"},{"key":"2266_CR23","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ejca.2009.04.006","volume":"45","author":"SK Kim","year":"2009","unstructured":"Kim SK, Choi HJ, Park SY et al (2009) Additional value of MR\/PET fusion compared with PET\/CT in the detection of lymph node metastases in cervical cancer patients. Eur J Cancer 45:2103\u20132109","journal-title":"Eur J Cancer"},{"key":"2266_CR24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845","journal-title":"Biometrics"},{"key":"2266_CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1148\/radiol.2371041444","volume":"237","author":"J Ward","year":"2005","unstructured":"Ward J, Robinson PJ, Guthrie JA et al (2005) Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237:170\u2013180","journal-title":"Radiology"},{"key":"2266_CR26","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1148\/radiol.10100729","volume":"257","author":"MC Niekel","year":"2010","unstructured":"Niekel MC, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and\/or FDG PET\/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674\u2013684","journal-title":"Radiology"},{"key":"2266_CR27","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00259-008-0743-z","volume":"35","author":"G Kong","year":"2008","unstructured":"Kong G, Jackson C, Koh DM et al (2008) The use of 18F-FDG PET\/CT in colorectal liver metastases\u2013comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 35:1323\u20131329","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2266_CR28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1259\/bjr.74.887.741065","volume":"74","author":"MP Debray","year":"2001","unstructured":"Debray MP, Geoffroy O, Laissy JP et al (2001) Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 74:1065\u20131070","journal-title":"Br J Radiol"},{"key":"2266_CR29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1148\/radiology.206.1.9423664","volume":"206","author":"EK Paulson","year":"1998","unstructured":"Paulson EK, McDermott VG, Keogan MT, DeLong DM, Frederick MG, Nelson RC (1998) Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 206:143\u2013150","journal-title":"Radiology"},{"key":"2266_CR30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1102\/1470-7330.2007.0002","volume":"7","author":"S Namasivayam","year":"2007","unstructured":"Namasivayam S, Martin DR, Saini S (2007) Imaging of liver metastases: MRI. Cancer Imaging 7:2\u20139","journal-title":"Cancer Imaging"},{"key":"2266_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jmri.1182","volume":"14","author":"TR Bader","year":"2001","unstructured":"Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT (2001) MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver. J Magn Reson Imaging 14:261\u2013269","journal-title":"J Magn Reson Imaging"},{"key":"2266_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/radiol.2371031842","volume":"237","author":"DA Bluemke","year":"2005","unstructured":"Bluemke DA, Sahani D, Amendola M et al (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 237:89\u201398","journal-title":"Radiology"},{"key":"2266_CR33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00004728-200605000-00001","volume":"30","author":"J Halavaara","year":"2006","unstructured":"Halavaara J, Breuer J, Ayuso C et al (2006) Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT\u2013a multicenter trial. J Comput Assist Tomogr 30:345\u2013354","journal-title":"J Comput Assist Tomogr"},{"key":"2266_CR34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3748\/wjg.v16.i13.1567","volume":"16","author":"PG Kele","year":"2010","unstructured":"Kele PG, van der Jagt EJ (2010) Diffusion weighted imaging in the liver. World J Gastroenterol 16:1567\u20131576","journal-title":"World J Gastroenterol"},{"key":"2266_CR35","unstructured":"Holzapfel K, Eiber MJ, Fingerle AA, Bruegel M, Rummeny EJ, Gaa J (2011) Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods Abdom Imaging. 2011 May 20. [Epub ahead of print]PMID: 21597893"},{"key":"2266_CR36","unstructured":"Kenis C, Deckers F, De Foer B, Van Mieghem F, Van Laere S, Pouillon M (2011) Diagnosis of liver metastases: Can diffusion-weighted imaging (DWI) be used as a stand alone sequence? Eur J Radiol. 2011 Mar 3. [Epub ahead of print] PMID: 21377305"},{"key":"2266_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000265561","volume":"91","author":"J Ruf","year":"2010","unstructured":"Ruf J, Heuck F, Schiefer J et al (2010) Impact of Multiphase 68Ga-DOTATOC-PET\/CT on therapy management in patients with neuroendocrine tumors. Neuroendocrinology 91:101\u2013109","journal-title":"Neuroendocrinology"},{"key":"2266_CR38","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/SLA.0b013e3181fd37e8","volume":"252","author":"A Frilling","year":"2010","unstructured":"Frilling A, Sotiropoulos GC, Radtke A et al (2010) The impact of 68Ga-DOTATOC positron emission tomography\/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg 252:850\u2013856","journal-title":"Ann Surg"},{"key":"2266_CR39","first-page":"359","volume":"44","author":"O Schillaci","year":"2003","unstructured":"Schillaci O, Spanu A, Scopinaro F et al (2003) Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med 44:359\u2013368","journal-title":"J Nucl Med"},{"key":"2266_CR40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0029-1215599","volume":"32","author":"RP Baum","year":"2009","unstructured":"Baum RP (2009) Molecular imaging of neuroendocrine tumors using 68Ga-labeled peptides (Somatostatin Receptor PET\/CT). Nuklearmediziner 32:115\u2013130","journal-title":"Nuklearmediziner"},{"key":"2266_CR41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/annonc\/mdg279","volume":"14","author":"M Cimitan","year":"2003","unstructured":"Cimitan M, Buonadonna A, Cannizzaro R et al (2003) Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role. Ann Oncol 14:1135\u20131141","journal-title":"Ann Oncol"},{"key":"2266_CR42","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s00259-008-0794-1","volume":"35","author":"M Rodrigues","year":"2008","unstructured":"Rodrigues M, Gabriel M, Heute D, Putzer D, Griesmacher A, Virgolini I (2008) Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe 1-Tyr 3-octreotide and chromogranin A assay in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 35:1796\u20131802","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2266_CR43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1055\/s-0030-1253354","volume":"42","author":"K Mussig","year":"2010","unstructured":"Mussig K, Oksuz MO, Dudziak K et al (2010) Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET\/CT in neuroendocrine tumors. Horm Metab Res 42:599\u2013606","journal-title":"Horm Metab Res"},{"key":"2266_CR44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000225946","volume":"90","author":"DJ Kwekkeboom","year":"2009","unstructured":"Kwekkeboom DJ, Krenning EP, Scheidhauer K et al (2009) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: somatostatin receptor imaging with (111)In-pentetreotide. Neuroendocrinology 90:184\u2013189","journal-title":"Neuroendocrinology"},{"key":"2266_CR45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/153303460500400512","volume":"4","author":"MD Seemann","year":"2005","unstructured":"Seemann MD (2005) Whole-body PET\/MRI: the future in oncological imaging. Technol Cancer Res Treat 4:577\u2013582","journal-title":"Technol Cancer Res Treat"},{"issue":"Suppl 1","key":"2266_CR46","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/s00259-008-0966-z","volume":"36","author":"RJ Hicks","year":"2009","unstructured":"Hicks RJ, Lau EW (2009) PET\/MRI: a different spin from under the rim. Eur J Nucl Med Mol Imaging 36(Suppl 1):S10\u201314","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2266_CR47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.beem.2007.01.003","volume":"21","author":"AG Rockall","year":"2007","unstructured":"Rockall AG, Reznek RH (2007) Imaging of neuroendocrine tumours (CT\/MR\/US). Best Pract Res Clin Endocrinol Metab 21:43\u201368","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2266_CR48","first-page":"1279","volume":"45","author":"AJ Lemke","year":"2004","unstructured":"Lemke AJ, Niehues SM, Hosten N et al (2004) Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions\u2013a prospective study with 104 patients. J Nucl Med 45:1279\u20131286","journal-title":"J Nucl Med"},{"key":"2266_CR49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00259-003-1379-7","volume":"31","author":"H Amthauer","year":"2004","unstructured":"Amthauer H, Ruf J, Bohmig M et al (2004) Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit? Eur J Nucl Med Mol Imaging 31:342\u2013348","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2266_CR50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00259-009-1205-y","volume":"37","author":"V Prasad","year":"2010","unstructured":"Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP (2010) Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET\/CT. Eur J Nucl Med Mol Imaging 37:67\u201377","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-011-2266-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-011-2266-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-011-2266-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:55:00Z","timestamp":1559044500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-011-2266-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,9]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1007\/s00330-011-2266-4","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,9]]}}}